Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Gynecologic Oncology

• Publication date

  1994-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1006/GYNO.1994.1271PMID 7959278
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients.

  1993cited by this paper
• Gynecologic tumors in tamoxifen‐treated women with breast cancer

  1993cited by this paper
• Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen.

  1993cited by this paper
• Gynecologic complications associated with long-term adjuvant tamoxifen therapy for breast cancer.

  1992cited by this paper
• A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer.

  1991cited by this paper
• Oncogenic potential of tamoxifen on endometria of postmenopausal women with breast cancer--preliminary report.

  1991cited by this paper
• New gynecologic cancer staging.

  1990cited by this paper
• Endometrial carcinoma in five patients with breast cancer on tamoxifen therapy.

  1990cited by this paper
• Four case reports presenting new acquisitions on the association between breast and endometrial carcinoma.

  1990cited by this paper
• Tamoxifen-associated endometrial carcinoma in postmenopausal breast cancer patients.

  1990cited by this paper
• Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers.

  1989cited by this paper
• Tamoxifen therapy in primary breast cancer: biology, efficacy, and side effects.

  1989cited by this paper
• Tamoxifen and the uterus and endometrium.

  1989cited by this paper
• Tamoxifen as risk factor for carcinoma of corpus uteri.

  1988cited by this paper
• Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.

  1988cited by this paper
• On the age-dependent association between cancer of the breast and of the endometrium. A nationwide cohort study.

  1987cited by this paper
• Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group study

  1987cited by this paper
• Endometrial adenocarcinoma in breast cancer patients receiving antiestrogens.

  1985cited by this paper
• Estrogen-like effects of tamoxifen on human endometrial carcinoma transplanted into nude mice.

  1984cited by this paper
• Clinical and pathological features and survival of endometrial cancer patients in relation to prior use of estrogens.

  1980cited by this paper

• Endometrial hyperplasia as a risk factor of endometrial cancer

  2022cites this paper
• Malignant diseases of the uterus

  2022cites this paper
• Concomitant diagnosis of endometrial and breast cancer - does the sequence matters?

  2021cites this paper
• Increased incidence of advanced stage endometrial cancer: a retrospective analysis of different clinical approaches and tumour biology

  2020cites this paper
• Changing Trends in the Epidemiology of Endometrial Cancer

  2020cites this paper
• Endometrial Carcinoma: Epidemiology and Risk Factors

  2019cites this paper
• Endometrial Carcinoma

  2019cites this paper
• Endometrial Cancer

  2019cites this paper
• Durable response in a woman with recurrent low-grade endometrioid endometrial cancer and a germline BRCA2 mutation treated with a PARP inhibitor.

  2018cites this paper
• Effects of Hormones

  2018cites this paper
• 5 – Adenocarcinoma of the Uterine Corpus

  2018cites this paper
• Prior breast cancer and tamoxifen exposure does not influence outcomes in women with uterine papillary serous carcinoma.

  2017cites this paper
• Chapter 2 Pathology of Gynecologic Cancer

  2017cites this paper
• Title Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer : SWOG S 9630

  2016cites this paper
• Tamoxifen Treatment and Risk of Endometrial Cancer： An Overview

  2016cites this paper
• Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630

  2016cites this paper
• Tamoxifen has a proliferative effect in endometrial carcinoma mediated via the GPER/EGFR/ERK/cyclin D1 pathway: A retrospective study and an in vitro study.

  2016cites this paper
• Evaluation of Metachronous Breast and Endometrial Cancers: Preroutine and Postroutine Adjuvant Tamoxifen Use

  2016cites this paper
• Omental Biopsy for Surgical Staging of Uterine Serous Carcinoma

  2016cites this paper
• Therapeutic Modalities in Early-Stage Uterine Papillary Serous Carcinomas, Carcinosarcomas, Clear-Cell and Mixed Histology Carcinomas: Treatment of Choice Is Combined Chemotherapy and Radiation

  2016cites this paper
• Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations.

  2016cites this paper
• Uterine papillary serous cancer

  2015cites this paper
• Endometrial evaluation by ultrasonography, hysteroscopy and histopathology in cases of breast carcinoma on Tamoxifen therapy

  2015cites this paper
• Screening and Prevention of Carcinoma Endometrium

  2015cites this paper
• Extended Adjuvant Tamoxifen for Early Breast Cancer: A Meta-Analysis

  2014cites this paper
• Committee Opinion No. 601: Tamoxifen and uterine cancer.

  2014cites this paper
• Case of uterine papillary serous carcinoma following tamoxifen treatment that could not be diagnosed during screening

  2014cites this paper
• Tamoxifen in breast cancer ipse dixit in uterine malignant mixed Müllerian tumor and sarcoma-A report of 8 cases and review of the literature.

  2013cites this paper
• Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial.

  2013cites this paper
• Erkrankungen des Endometriums

  2013cites this paper
• Sonohysterography for evaluation of endometrial abnormalities associated with tamoxifen therapy for breast cancer

  2013cites this paper
• Pathology of Gynecologic Cancer

  2013cites this paper
• [Tamoxifen and endometrial disease in patients with breast cancer].

  2013cites this paper
• Uterine papillary serous cancer: a review of the literature.

  2012cites this paper
• Clinico-pathologic comparison of type II endometrial cancers based on tamoxifen exposure.

  2012cites this paper
• 32-Neoplastic Diseases of the Uterus

  2012cites this paper
• Effects of tamoxifen on the endometrium and its mechanism of carcinogenicity

  2011cites this paper
• Personal history of breast cancer as a significant risk factor for endometrial serous carcinoma in women aged 55 years old or younger

  2011cites this paper
• Selected Topics in the Molecular Pathology of Endometrial Carcinoma.

  2011cites this paper
• 49 – Cancer of the Endometrium

  2010cites this paper
• Sarcomi uterini: esperienza monocentrica e review della letteratura

  2010cites this paper
• Relationship between tamoxifen use and high risk endometrial cancer histologic types.

  2009cites this paper
• Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review.

  2009cites this paper
• Uterine malignancy following tamoxifen use in breast cancer patients in Iran: case series and literature review.

  2009cites this paper
• Integrating ontologies and argumentation for decision-making in breast cancer

  2009cites this paper
• Alterations of the K-ras and p53 genes in Tamoxifen-associated endometrial carcinoma.

  2008cites this paper
• Tamoxifen and giant endometrial polyp.

  2008cites this paper
• Tamoxifen and Uterine Cancer

  2008cites this paper
• Clinical aspects of uterine papillary serous carcinoma

  2008cites this paper
• Tumorigenic Effects of Tamoxifen on the Female Genital Tract

  2008influential citation
• Neoplastic Diseases of the Uterus

  2007cites this paper
• 8.08 – Tamoxifen

  2007cites this paper
• Tamoxifen: important considerations of a multi-functional compound with organ-specific properties.

  2007cites this paper
• Outcomes in patients with primary breast cancer and a subsequent diagnosis of endometrial cancer

  2007cites this paper
• Chapter 5 – Adenocarcinoma of the Uterus

  2007cites this paper
• Introduction to Endometrial Cancer

  2007cites this paper
• Toremifene: an evaluation of its safety profile.

  2006cites this paper
• Conclusions: Considerations regarding SERMs.

  2006cites this paper
• Comparison of uterine malignancies that develop during and following tamoxifen therapy.

  2006cites this paper
• Breast cancer followed by corpus cancer: is there a higher risk for aggressive histologic subtypes?

  2006cites this paper
• My approach to the interpretation of endometrial biopsies and curettings

  2006cites this paper
• Pathogenesis of Histological Types of Endometrial Cancer

  2006cites this paper
• Sarcomas de útero después de tratamiento con tamoxifeno por cáncer

  2005cites this paper
• A review of the pathology and management of uterine papillary serous carcinoma and correlation with outcome

  2005cites this paper
• Is tamoxifen associated with high-risk endometrial carcinomas? A retrospective case series of 196 women with endometrial cancer

  2005cites this paper
• Controversias en la prevención de patología endometrial en mujeres en tratamiento con tamoxifeno

  2005cites this paper
• Gynecologic effects of tamoxifen: Case reports and review of the literature

  2005cites this paper
• Tamoxifen and endometrial cancer. Is screening necessary? A review of the literature.

  2005cites this paper
• Endometrial cancer and tamoxifen.

  2005cites this paper
• Molecular genetic characterization of tamoxifen-associated endometrial cancer.

  2005cites this paper
• Endometrial pathologies associated with postmenopausal tamoxifen treatment.

  2004cites this paper
• Gene expression profiling of tamoxifen-associated uterine cancers: evidence for two molecular classes of endometrial carcinoma.

  2004cites this paper
• The effects of tamoxifen on the endometrium

  2004cites this paper
• The effects of tamoxifen on the female genital tract.

  2004cites this paper
• Does Tamoxifen Use Affect Prognosis in Breast Cancer Patients Who Develop Endometrial Cancer?

  2004cites this paper
• Association between uterine serous carcinoma and breast cancer.

  2004cites this paper
• Clinicopathologic study of 56 patients with endometrial cancer during or after adjuvant tamoxifen use for their breast cancers.

  2004cites this paper
• “Studies on the estrogen receptor in breast cancer” — 20 years as a target for the treatment and prevention of cancer

  2004influential citation
• The gynaecological management of women on tamoxifen: a national questionnaire survey

  2004influential citation
• Tumeurs mixtes müllériennes de l’endomètre. À propos de quatre cas développés sous tamoxifène

  2003cites this paper
• [Mixed müllerian tumours of the endometrium. About four cases developed on tamoxifen treatment].

  2003cites this paper
• Effects of tamoxifen on the human female genital tract: review of the literature.

  2003cites this paper
• Environmental factors and risk for endometrial cancer development.

  2003cites this paper
• Tamoxifen for Prevention of Breast Cancer

  2003cites this paper
• Breast cancer chemoprevention: risk-benefit effects of the antioestrogen tamoxifen

  2002cites this paper
• Diagnóstico precoz de carcinoma de endometrio en una paciente tratada con tamoxifeno

  2002cites this paper
• Adjuvant Tamoxifen

  2002cites this paper
• The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium.

  2002cites this paper
• Tamoxifen‐induced endometrial changes in postmenopausal women with breast carcinoma

  2002cites this paper
• Survival Impact of Tamoxifen Use for Breast Cancer Risk Reduction: Projections from a Patient-Specific Markov Model

  2002cites this paper
• Aggressive endometrial carcinoma in a breast cancer patient treated with tamoxifen with normal transvaginal ultrasonography. Case report.

  2002cites this paper
• Endometrial mixed Müllerian tumor with heterologous elements following tamoxifen therapy for breast cancer: a case report and literature review.

  2002cites this paper
• Endometrial disorders in 406 breast cancer patients on tamoxifen: the case for less intensive monitoring.

  2002cites this paper
• Breast cancer: risk, prevention, & tamoxifen.

  2001cites this paper
• Considerations Regarding SERMs

  2001cites this paper
• Role of Exogenous and Endogenous Hormones in Endometrial Cancer

  2001cites this paper
• Tamoxifeno y Patología Endometrial

  2001cites this paper
• Risk factors of endometrial polyps resected from postmenopausal patients with breast carcinoma treated with tamoxifen

  2001cites this paper
• Tamoxifen and the female reproductive tract

  2001cites this paper
• The Role of Tamoxifen in Breast Cancer Prevention

  2001cites this paper